Solid Biosciences (SLDB) Total Non-Current Liabilities (2018 - 2024)
Historic Total Non-Current Liabilities for Solid Biosciences (SLDB) over the last 5 years, with Q3 2024 value amounting to $22.0 million.
- Solid Biosciences' Total Non-Current Liabilities changed N/A to $22.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $22.0 million, marking a year-over-year change of. This contributed to the annual value of $23.9 million for FY2023, which is 5062.69% down from last year.
- Latest data reveals that Solid Biosciences reported Total Non-Current Liabilities of $22.0 million as of Q3 2024.
- In the past 5 years, Solid Biosciences' Total Non-Current Liabilities ranged from a high of $48.5 million in Q4 2022 and a low of $22.0 million during Q3 2024
- Moreover, its 4-year median value for Total Non-Current Liabilities was $23.9 million (2023), whereas its average is $31.0 million.
- The largest annual percentage gain for Solid Biosciences' Total Non-Current Liabilities in the last 5 years was 5062.69% (2023), contrasted with its biggest fall of 5062.69% (2023).
- Over the past 4 years, Solid Biosciences' Total Non-Current Liabilities (Quarter) stood at $37.8 million in 2020, then increased by 28.34% to $48.5 million in 2022, then crashed by 50.63% to $23.9 million in 2023, then fell by 8.32% to $22.0 million in 2024.
- Its last three reported values are $22.0 million in Q3 2024, $23.0 million for Q2 2024, and $23.9 million during Q4 2023.